Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Flu Ushers In Risky Claims Season

This article was originally published in The Tan Sheet

Executive Summary

Supplement firms are safest avoiding any mention of the flu, and trade groups see flu claims as a red flag for other problems. But flu season perennially brings in claims that skirt – or cross – the line, where they could draw fire from FDA.

Advertisement

Related Content

Ebola Crisis Causes Drug Claim Symptoms In Products Marketed As Supplements
Ebola Crisis Causes Drug Claim Symptoms In Products Marketed As Supplements
Regulatory News In Brief
FTC Stakes New Territory, Joins FDA In Warning On H1N1 Claims

Topics

Advertisement
UsernamePublicRestriction

Register

PS106182

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel